Explore the words cloud of the IBEX QDR project. It provides you a very rough idea of what is the project "IBEX QDR" about.
The following table provides information about the project.
Coordinator |
IBEX INNOVATIONS LTD
Organization address contact info |
Coordinator Country | United Kingdom [UK] |
Project website | http://ibexinnovations.co.uk |
Total cost | 1˙611˙542 € |
EC max contribution | 1˙611˙542 € (100%) |
Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
Code Call | H2020-SMEINST-2-2016-2017 |
Funding Scheme | SME-2 |
Starting year | 2017 |
Duration (year-month-day) | from 2017-08-01 to 2020-01-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | IBEX INNOVATIONS LTD | UK (SEDGEFIELD) | coordinator | 1˙611˙542.00 |
Bone density loss is a natural process that affects us all as we age. As the loss advances, so does the risk of fracture. The lack of warning symptoms or routine tests results in a late detection of severe density loss (osteoporosis), often when the first fracture occurs. Besides being a major social burden, in the EU it entails costs of €37 bn/year in treatment, disability or productivity loss, which could be alleviated if population-wide bone health screening methods were available. Today, measurement of bone mineral density (BMD) is only available through scarce and expensive DEXA scans, limiting testing to referred individuals grouped as high risk of osteoporosis. In response, we at IBEX Innovations have developed and patented IBEX-Quantitative Digital Radiography (IBEX-QDR). Conceived as a cost-efficient upgrade for standard digital radiography systems, it enhances the quality of digital X-ray images and enables these systems to measure BMD. All while reducing by 2-fold the X-ray dose needed to obtain the image. Altogether, IBEX QDR will unleash the diagnostic potential of digital radiology, enabling routine screening of bone density with any standard X-ray examination. In a Phase 1 project we confirmed the market opportunities for IBEX-QDR, outlined technical optimisations and achieved high-level engagement with X-ray detector and system manufacturers and healthcare providers. Now in Phase 2 we aim to reach market readiness by finalising the technological development, completing its clinical validation and securing the business aspects of the project. Once in the market, IBEX QDR will bring significant benefits for healthcare systems (early diagnosis and lower impact of ageing diseases), professionals (safer and simplified work-flows) and public health (lower radiation dose and less X-ray induced cancer). In turn, in 5 years it will provide us €16.7 million profits, 16 new people and a ROI of €9.37 per euro invested, representing c.1% of the target market.
Updated Marketing materials (Brochures, website) | Websites, patent fillings, videos etc. | 2020-04-25 01:45:01 |
Software Sign-off and Release | Other | 2020-04-25 01:45:11 |
Take a look to the deliverables list in detail: detailed list of IBEX QDR deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IBEX QDR" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IBEX QDR" are provided by the European Opendata Portal: CORDIS opendata.